Results 201 to 210 of about 12,958 (242)
Some of the next articles are maybe not open access.
Current Biology
Several species of fungi, collectively known as 'psychedelic fungi', produce a range of psychoactive substances, such as psilocybin, ibotenic acid, muscimol and lysergic acid amides. These substances interact with neurotransmitter receptors in the human brain to induce profound psychological effects.
Jason, Slot, Dirk, Hoffmeister
openaire +2 more sources
Several species of fungi, collectively known as 'psychedelic fungi', produce a range of psychoactive substances, such as psilocybin, ibotenic acid, muscimol and lysergic acid amides. These substances interact with neurotransmitter receptors in the human brain to induce profound psychological effects.
Jason, Slot, Dirk, Hoffmeister
openaire +2 more sources
Journal of Psychoactive Drugs, 2005
The use of psychedelic substances within a context that emphasizes religious experiences and aims to provide spiritual insights is not a new phenomenon. However, the proscription of these substances in most modern societies leads to such use now typically occurring in an underground and idiosyncratic manner that often leaves individuals on their own ...
openaire +2 more sources
The use of psychedelic substances within a context that emphasizes religious experiences and aims to provide spiritual insights is not a new phenomenon. However, the proscription of these substances in most modern societies leads to such use now typically occurring in an underground and idiosyncratic manner that often leaves individuals on their own ...
openaire +2 more sources
Compassionate use of psychedelics
Medicine, Health Care and Philosophy, 2020In the present paper, we discuss the ethics of compassionate psychedelic psychotherapy and argue that it can be morally permissible. When talking about psychedelics, we mean specifically two substances: psilocybin and MDMA. When administered under supportive conditions and in conjunction with psychotherapy, therapies assisted by these substances show ...
Adam Greif, Martin Šurkala
openaire +2 more sources
The history of psychedelics and why psychedelic stories matter
Open Access Government, 2023The history of psychedelics and why psychedelic stories matter Erika Dyck argues that how people learn about psychedelics today matters, based on the histories of these drugs and how they have been and should be used in clinical medicine.
openaire +1 more source
The term psychedelic was formally introduced in 1957 to mean “mind manifesting” or “to bring to light,” but the phenomenon of seeking nonordinary states of consciousness has long and diverse roots. Psychedelic substances are associated with plants, fungi, animals, and synthetic substances that can cause changes in consciousness and hallucinations ...
+5 more sources
+5 more sources
Why Psychiatry Needs Psychedelics and Psychedelics Need Psychiatry
Journal of Psychoactive Drugs, 2014Without researching psychedelic drugs for medical therapy, psychiatry is turning its back on a group of compounds that could have great potential. Without the validation of the medical profession, the psychedelic drugs, and those who take them off-license, remain archaic sentiments of the past, with the users maligned as recreational drug abusers and ...
openaire +2 more sources
Psychiatric Residents’ Perspectives on Psychedelics and Psychedelic Assisted Therapy
Journal of Psychoactive DrugsThis study evaluated the attitudes, knowledge, and educational experiences of psychiatry residents regarding psychedelics and psychedelic-assisted therapy (PAT). In 2023, we distributed an anonymous survey to United States psychiatry residents, assessing demographics, knowledge, and opinions on psychedelics/PAT.
Brian S. Barnett +6 more
openaire +2 more sources
Psychedelic-inspired drug discovery using an engineered biosensor
Cell, 2021Chunyang Dong +2 more
exaly
Psychedelics in Psychiatry, the Nursing Influence, and the Future of Psychedelic Therapies
Journal of the American Psychiatric Nurses AssociationOBJECTIVE: Psychedelics and psychedelic-assisted therapies (PATs) are on the cusp of becoming medicalized treatment modalities within the United States, both as potential U.S. Food and Drug Administration (FDA)-approved treatment and therapeutic options outside the medical model, through decriminalization ...
openaire +2 more sources